Topics
CNS Tumors | Treatment | Antiepileptic drugs
Home > Publications > Topics > CNS Tumors > Treatment > Antiepileptic drugs
Thavaneswaran S, Sim HW, Grady J, Espinoza D, Huang ML, Lin F,
McGrath M, Desai J, Charakidis M, Brown M, Kansara M, Simes J,
Thomas D.
A phase II trial of
larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA
overexpression identified by comprehensive genomic profiling.
Oncologist.
2024 Dec 25:oyae339. doi:
10.1093/oncolo/oyae339. PMID:
39720993. Interventional study. ˍ